Ibrutinib (Imbruvica), developed by the J & J pharmaceutical company is significantly more effective than standard chemotherapy for leukemia.During the trial, some patients with chronic lymphocytic leukemia received ibrutinib, and some patients received chemotherapy. It turned out t...